💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for KaloBios Pharmaceuticals, Inc. (KBIO)
« Back to company indexKBIO Chatter Timeline
Stock Ticker for KBIO
Most Active Tweeters for KBIO
| User | Tweets |
|---|---|
| @krugermacrro | 11 |
| @FlashAlert_me | 5 |
| @blackjackblack | 1 |
| @making_sales | 1 |
| @ZeusHercInvest | 1 |
Recent Tweets for KBIO
 |
@FlashAlert_me $KBIO [15s. delayed] filed form 8-K on December 02, 08:00:23 https://t.co/vG6vXUSQwl December 2nd 2021, 1:12pm |
 |
@making_sales @Hercules_Trader I was around there but $KBIO was pretty crazy from what I’ve heard. $KODK was a first of its kind… https://t.co/Sji90d4Ydb December 1st 2021, 9:12am |
 |
@blackjackblack @Guruleaks1 This guy with $KBIO, he’s smart could have made something of himself but chose wrong path. November 30th 2021, 3:11am |
 |
@krugermacrro RT @lx21: $KBIOQ short interest at Interactive Brokers is now under 1%. Just a few months ago the fee was around 350% at most firms. $KBIO November 29th 2021, 10:11pm |
|
@krugermacrro RT @lx21: Last time there was news on lenzilumab $KBIO jumped 7% & market cap was $10M. Only diff is Shkreli buys float & lenzilumab is a m… November 29th 2021, 10:11pm |
|
@krugermacrro RT @lx21: Shkreli alone now owns 50.12% of $KBIO November 29th 2021, 10:11pm |
|
@krugermacrro RT @lx21: Trading can be so fun and rewarding when things are going well, but absolute torture when they are not. $KBIO November 29th 2021, 10:11pm |
|
@krugermacrro RT @lx21: I survived this $KBIO calamity, but it was not fun. I'll keep my promise to donate to charity. November 29th 2021, 10:11pm |
|
@krugermacrro RT @lx21: It goes without saying that $KBIO was a terrible call and trade on my part. I apologize to anyone who followed my idea. November 29th 2021, 10:11pm |
|
@krugermacrro RT @lx21: Yahoo Finance and other sources are using outdated filings to calculate the $KBIO book value. They are now completely outdated &… November 29th 2021, 10:11pm |
|
@krugermacrro RT @lx21: I'll post $KBIO research within the next couple of days. All the numbers are in Excel, but I still need to write out an explanati… November 29th 2021, 10:11pm |
|
@krugermacrro RT @lx21: yet I think it is still conceivable that current $KBIO shareholders could be left with much less than $0.63. November 29th 2021, 10:11pm |
|
@krugermacrro RT @lx21: After crunching the numbers many hours and using conservative estimates I believe $KBIO will be worth $0.63 per share at liquidat… November 29th 2021, 10:11pm |
|
@krugermacrro RT @lx21: Yahoo Finance shows $KBIO book value is $2.53 per share. But that was as of June 30. A lot has changed in only 4 1/2 months. November 29th 2021, 10:11pm |
|
@FlashAlert_me $KBIO [15s. delayed] filed SEC form 4: Chief Commercial Officer Jordan Edward P.: Transacted Derivative Securities… https://t.co/4JsT2sqZlm November 26th 2021, 10:11pm |
|
@FlashAlert_me $KBIO [15s. delayed] filed SEC form 4: Chief Executive Officer Durrant Cameron: Transacted Derivative Securities o… https://t.co/VeQGcjR2kG November 26th 2021, 10:11pm |
|
@FlashAlert_me $KBIO [15s. delayed] filed SEC form 4: Chief Medical Officer Kilcoyne Adrian: Transacted Derivative Securities on… https://t.co/Mdc5o9W0OA November 26th 2021, 10:11pm |
|
@FlashAlert_me $KBIO [15s. delayed] filed form 8-K on November 26, 17:00:34 https://t.co/1Z3VpQlsu2 November 26th 2021, 10:11pm |
 |
@greg__foster @mongollidtrade $LGVN for a mega $KBIO infinity squeeze? Could use your firepower. November 26th 2021, 4:11pm |
 |
@defijackworth RT @ZeusHercInvest: $APVO would love to see it do the $KBIO nasty blasty and ruin shorties forever! OHHHHHHHH!!! November 24th 2021, 4:11am |
 |
@ZeusHercInvest $APVO would love to see it do the $KBIO nasty blasty and ruin shorties forever! OHHHHHHHH!!! November 23rd 2021, 6:11pm |
 |
@RTrader1988 RT @MoxReports: Friendly annual $KBIO reminder. The biggest short squeezes in history often began during holiday shortened weeks like than… November 19th 2021, 4:11pm |
 |
@MoxReports @altum_research See my second tweet above. The fact that Shkreli ran his $KBIO squeeze during holiday shortened th… https://t.co/8RN8hxsTBe November 19th 2021, 4:11pm |
|
@MoxReports Friendly annual $KBIO reminder. The biggest short squeezes in history often began during holiday shortened weeks l… https://t.co/zs2oEPL9wh November 19th 2021, 4:11pm |
 |
@Aldinho_lbk $PROG Those of us who have been around the block several times, knows $KBIO story, when short sellers lost their ho… https://t.co/naXRJlCBlY November 17th 2021, 1:11pm |
|
@Aldinho_lbk $PROG Is among the horrible nightmare a short seller can have... Only $KBIO have been the worst. Who remember KBIO and the #PharmaBro? November 17th 2021, 10:11am |
 |
@duncanbracey I made $1,258 (56%) trading $KBIO, beating the stock! And beating the market! Play the @business Trading Game: https://t.co/d63hMh4V8u November 5th 2021, 7:11pm |
 |
@TradeThePattern @Hugh_Henne That sucks, it reminds me of $KBIO and the dude that blew up in the same manner November 3rd 2021, 11:11pm |
 |
@Kristaps_EQ Lets go to $200 and call it a $KBIO 2.0 day. https://t.co/roh02GUJC0 October 22nd 2021, 12:10pm |
 |
@jonerik1984 RT @kroyrunner89: $APVO omg wow, straight out of the $KBIO playbook October 16th 2021, 7:10pm |
|
@FlashAlert_me $KBIO [15s. delayed] filed form 8-K on October 05, 16:05:36 https://t.co/iT7297s8M0 October 5th 2021, 8:10pm |
|
@FlashAlert_me $KBIO [15s. delayed] filed SEC form 4: Chief Scientific Officer Chappell Dale: Transacted Derivative Securities on… https://t.co/GW0NN3B1uh October 5th 2021, 12:10am |
|
@FlashAlert_me $KBIO [15s. delayed] filed SEC form 4: Chief Executive Officer Durrant Cameron: Transacted Derivative Securities o… https://t.co/mflh3nFIrQ October 5th 2021, 12:10am |
|
@FlashAlert_me $KBIO [15s. delayed] filed SEC form 4: Chief Commercial Officer Jordan Edward P.: Transacted Derivative Securities… https://t.co/ckXo4QVBEy October 5th 2021, 12:10am |
|
@FlashAlert_me $KBIO [15s. delayed] filed SEC form 4: Chief Medical Officer Kilcoyne Adrian: Transacted Derivative Securities on… https://t.co/HeUkFm2Y7R October 5th 2021, 12:10am |
 |
@_nefficientmrkt RT @inefficientmrkt: found this oldie in the closet. blood, sweat, & tears found on that plot lol. i think those 2 pulls were $KBIO & $DRYS… September 18th 2021, 12:09am |
 |
@Dangster19 RT @SamueluSheck: Its cheaper to squeeze from a cheaper price than a higher price. If history repeats itself(check $KBIO) then we'll see $G… September 15th 2021, 5:09pm |
 |
@SamueluSheck Its cheaper to squeeze from a cheaper price than a higher price. If history repeats itself(check $KBIO) then we'll… https://t.co/uIP3Dpqddb September 15th 2021, 4:09pm |
 |
@Kroyrunner20 $APVO omg wow, straight out of the $KBIO playbook September 15th 2021, 2:09pm |
|
@FlashAlert_me $KBIO [15s. delayed] filed form 8-K on September 14, 17:00:46 https://t.co/fjfnYZZ4WB September 14th 2021, 9:09pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
DrugPatentWatch Video Training
Decision-making for generic drug entry and branded drug lifecycle management
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
This course answers the following questions to help you adapt:
- ✓ When will key drug patents expire?
- ✓ How can I find, evaluate, and plan for generic market entry opportunities?
- ✓ How can I find proprietary out-of-court settlements and deal terms?